Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Global Future City Holding Inc stock logo
FTCY
Global Future City
$0.00
$0.05
$1.00
$2.04M-0.614,221 shs16 shs
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
$0.22
+5.4%
$0.00
$0.94
$7.76
$643K0.721.63 million shs210,785 shs
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
$0.53
-3.0%
$0.71
$0.37
$108.00
$2.41M-0.13718,206 shs49,511 shs
VGLS
VG Life Sciences
$0.00
$0.00
$0.00
$0.00
$2.11M1.817.89 million shs31.50 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Global Future City Holding Inc stock logo
FTCY
Global Future City
0.00%0.00%0.00%0.00%0.00%
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
0.00%+16.76%-4.55%-88.75%-88.75%
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
0.00%+25.50%-12.51%-67.27%-99.15%
VGLS
VG Life Sciences
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/AN/AN/AN/AN/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
N/AN/AN/AN/AN/AN/AN/AN/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/AN/AN/AN/A
VGLS
VG Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Global Future City Holding Inc stock logo
FTCY
Global Future City
0.00
N/AN/AN/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
0.00
N/AN/AN/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
0.00
N/AN/AN/A
VGLS
VG Life Sciences
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/AN/AN/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
$19.81M0.03$0.05 per share4.38$1.76 per share0.12
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/A($61.61) per shareN/A
VGLS
VG Life Sciences
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/A0.00N/AN/AN/AN/AN/AN/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
-$2.05MN/AN/AN/A-61.42%-162.54%-49.94%N/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
-$51.16MN/A0.00N/AN/AN/AN/AN/A
VGLS
VG Life Sciences
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/AN/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
N/AN/AN/AN/AN/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/A
VGLS
VG Life Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
3.30
0.95
0.95
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/A
0.64
0.64
VGLS
VG Life Sciences
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
6.31%
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
77.44%
VGLS
VG Life Sciences
N/A

Insider Ownership

CompanyInsider Ownership
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/A
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
24.20%
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
3.60%
VGLS
VG Life Sciences
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/A40.66 millionN/ANot Optionable
NTN Buzztime, Inc. stock logo
NTN
NTN Buzztime
192.98 millionN/ANot Optionable
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/A4.53 million6.36 millionN/A
VGLS
VG Life Sciences
121.10 billionN/ANot Optionable

Recent News About These Companies

VG Life Sciences Inc.
VG Life Sciences Inc. (VGLS)
VG Life Sciences Inc VGLS
Report warns of 'oversupply' of life sciences real estate
VGLS VG Life Sciences Inc.

Media Sentiment Over Time

Global Future City stock logo

Global Future City OTCMKTS:FTCY

Global Future City Holding, Inc. is an holding company. It focused in the areas of consumer product sales and EB-5 investments. The company was founded on October 12, 2000 and is headquartered in Irvine, CA.

NTN Buzztime stock logo

NTN Buzztime NYSEAMERICAN:NTN

$0.22 +0.01 (+5.42%)
As of 04/25/2025

NTN Buzztime, Inc., together with its subsidiaries, provides interactive entertainment and technology to bars, restaurants, casinos, and senior living centers in the United States and Canada. Its principal product and service is its tablet platform. The company also leases equipment, including tablets, and cases and charging trays for the tablets to various network subscribers. It also licenses its content to customers to be installed on equipment that they obtain from other parties. The company's interactive entertainment system offers trivia, card, sports, and arcade games. It owns various trademarks, including the Buzztime, Playmaker, Mobile Playmaker, and BEOND Powered. As of June 30, 2020, NTN Buzztime, Inc. served 1,219 venues with its interactive entertainment network. The company was formerly known as NTN Communications, Inc. and changed its name to NTN Buzztime, Inc. in 2005. NTN Buzztime, Inc. was founded in 1982 and is based in Carlsbad, California.

Psyence Biomedical stock logo

Psyence Biomedical NASDAQ:PBM

$0.53 -0.02 (-3.00%)
Closing price 03:59 PM Eastern
Extended Trading
$0.55 +0.02 (+3.88%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.

VG Life Sciences OTCMKTS:VGLS

$0.0001 0.00 (0.00%)
As of 03:34 PM Eastern

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd.